However, in addition to PD-L1 signaling, negative factors, such as immunosuppressive cells, cytokines, cancer-associated adipocytes, overactive cancer-associated fibroblasts, other immune checkpoints, and aberrant angiogenesis, can all influence cancer-immune set points and create an environment of immune tolerance. The gene discussed is CD274; the disease is cancer.